Cargando…

Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes

The stimulation of insulin secretion by glucose can be modulated by multiple nutritive, hormonal, and pharmacological inputs. Fatty acids potentiate insulin secretion through the generation of intracellular signaling molecules and through the activation of cell surface receptors. The G-protein–coupl...

Descripción completa

Detalles Bibliográficos
Autor principal:	Burant, Charles F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Diabetes Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920793/ https://www.ncbi.nlm.nih.gov/pubmed/23882043 http://dx.doi.org/10.2337/dcS13-2037

Ejemplares similares

Is Physical Exercise a Core Therapeutical Element for Most Patients With Type 2 Diabetes?
por: De Feo, Pierpaolo, et al.
Publicado: (2013)

How Do We Continue Treatment in Patients With Type 2 Diabetes When Therapeutic Goals Are Not Reached With Oral Antidiabetes Agents and Lifestyle? Incretin versus insulin treatment
por: Gallwitz, Baptist, et al.
Publicado: (2013)

Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013
por: Schernthaner, Guntram, et al.
Publicado: (2013)

In Vivo Actions of Peroxisome Proliferator–Activated Receptors: Glycemic control, insulin sensitivity, and insulin secretion
por: Eldor, Roy, et al.
Publicado: (2013)

Management of Type 2 Diabetes in Stage C Heart Failure with Reduced Ejection Fraction
por: Agarwalla, Anjali, et al.
Publicado: (2022)

Treatment of Type 2 Diabetes in Youth
por: Flint, Amanda, et al.
Publicado: (2011)

Multiagonist Unimolecular Peptides for Obesity and Type 2 Diabetes: Current Advances and Future Directions
por: Hasib, Annie
Publicado: (2020)

Therapeutic Targets for Type 2 Diabetes Post-UKPDS
por: Yudkin, John S
Publicado: (2000)

Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoids
por: Fenton, Chloe, et al.
Publicado: (2021)

Insulin as an Early Treatment for Type 2 Diabetes: ORIGIN or end of an old question?
por: Del Prato, Stefano, et al.
Publicado: (2013)

Insulin Pump for Type 2 Diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes
por: Reznik, Yves, et al.
Publicado: (2013)

Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
por: Palmer, Allyson K., et al.
Publicado: (2015)

Developments in the Management of Type 1 and Type 2 Diabetes
por: Mathieu, Chantal
Publicado: (2018)

Premises for Cholecystokinin and Gastrin Peptides in Diabetes Therapy
por: Rehfeld, Jens F
Publicado: (2019)

Glucagon-like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth
por: Berman, Casey, et al.
Publicado: (2023)

Expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction in insulin-naïve patients with type 2 diabetes
por: Naegeli, A N, et al.
Publicado: (2010)

Changes in treatment of hyperglycemia in a hypertensive type 2 diabetes population as renal function declines
por: Weinrauch, Larry A., et al.
Publicado: (2017)

Diagnostic and therapeutic guidelines for migraine. Italian Society for the Study of Headaches (SISC)
por: Gallai, Virgilio, et al.
Publicado: (2001)

Type 2 Diabetes in Youth: Epidemiology and Pathophysiology
por: D’Adamo, Ebe, et al.
Publicado: (2011)

Pathophysiology of Type 2 Diabetes in Children and Adolescents
por: Valaiyapathi, Badhma, et al.
Publicado: (2020)

OR24-3 GPR31 Mediates the Proinflammatory Reponses in the Setting of Diabetic Inflammation
por: Anderson, Ryan, et al.
Publicado: (2022)

Progression to hypertension in youth and young adults with type 1 or type 2 diabetes: The SEARCH for Diabetes in Youth Study
por: Koebnick, Corinna, et al.
Publicado: (2020)

Is Type 2 Diabetes Mellitus a Behavioural Disorder? An Evidence Review for Type 2 Diabetes Mellitus Prevention and Remission through Lifestyle Modification
por: Li, Matthias, et al.
Publicado: (2023)

Epigenetics of the Pathogenesis and Complications of Type 2 Diabetes Mellitus
por: Mannar, Velmurugan, et al.
Publicado: (2023)

Tirzepatide: A Novel, Once-weekly Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes
por: Kaneko, Shizuka
Publicado: (2022)

Ginseng Gintonin Contains Ligands for GPR40 and GPR55
por: Cho, Yeon-Jin, et al.
Publicado: (2020)

Nutrient-Sensing Mechanisms in the Gut as Therapeutic Targets for Diabetes
por: Breen, Danna M., et al.
Publicado: (2013)

Combining Incretin-Based Therapies With Insulin: Realizing the potential in type 2 diabetes
por: Vora, Jiten
Publicado: (2013)

Clinical characteristics and patient treatment satisfaction with Humalog U-200 in patients with type 2 diabetes mellitus: an observational study
por: Mamza, Jil, et al.
Publicado: (2019)

Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus
por: Profit, Louise, et al.
Publicado: (2008)

The Cost-effectiveness of a Flash Glucose Monitoring System for Management of Patients with Type 2 Diabetes Receiving Intensive Insulin Treatment in Sweden
por: Bilir, S Pinar, et al.
Publicado: (2018)

Defining Disease Progression and Drug Durability in Type 2 Diabetes Mellitus
por: Kalra, Sanjay, et al.
Publicado: (2019)

SAT070 The G Protein Coupled Receptor GPR31 Promotes Islet Inflammation And Diabetes
por: Checkcinco, Christian, et al.
Publicado: (2023)

The effect of omega‐3 fatty acids on active periodontal therapy: A systematic review and meta‐analysis
por: Van Ravensteijn, Myrlon M., et al.
Publicado: (2022)

Diabetic kidney disease in type 2 diabetes: a review of pathogenic mechanisms, patient-related factors and therapeutic options
por: Woodhams, Louise, et al.
Publicado: (2021)

Adherence to a healthy lifestyle and the risk of type 2 diabetes in Chinese adults
por: Lv, Jun, et al.
Publicado: (2017)

Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes
por: Bajaj, Harpreet S, et al.
Publicado: (2023)

The trends and the risk of type 1 diabetes over the past 40 years: an analysis by birth cohorts and by parental migration background in Sweden
por: Hussen, Hozan Ismael, et al.
Publicado: (2013)

New strategies for the treatment of migraine attacks
por: Genco, Sergio, et al.
Publicado: (2001)

Effects of Sacubitril/Valsartan on Exercise Capacity in Patients with Heart Failure with Reduced Ejection Fraction and the Role of Percentage of Delayed Enhancement Measured by Cardiac Magnetic Resonance in Predicting Therapeutic Response: A Multicentre Study
por: Nugara, Cinzia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b531ienh6vhineapl7gg4rc31r